Walleye Trading LLC United Therapeutics Corp Call Options Transaction History

Walleye Trading LLC

  • $46.7 Billion
  • Q3 2024

Call Options

26 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$311.04 - $363.55 $435,456 - $508,970
1,400 Added 175.0%
2,200 $788,000
Q2 2024

Aug 14, 2024
SELL
$228.26 - $319.04 $2.83 Million - $3.96 Million
-12,400 Reduced 93.94%
800 $254,000
Q1 2024

May 15, 2024
BUY
$210.76 - $249.51 $2.28 Million - $2.69 Million
10,800 Added 450.0%
13,200 $3.03 Million
Q4 2023

Feb 14, 2024
BUY
$214.88 - $256.94 $107,440 - $128,470
500 Added 26.32%
2,400 $527,000
Q3 2023

Nov 14, 2023
BUY
$211.82 - $248.24 $254,184 - $297,888
1,200 Added 171.43%
1,900 $429,000
Q2 2023

Aug 14, 2023
SELL
$205.19 - $232.99 $20,519 - $23,299
-100 Reduced 12.5%
700 $154,000
Q1 2023

May 15, 2023
SELL
$212.99 - $276.17 $63,897 - $82,851
-300 Reduced 27.27%
800 $179,000
Q4 2022

Feb 14, 2023
BUY
$205.95 - $280.43 $61,785 - $84,129
300 Added 37.5%
1,100 $305,000
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $325,280 - $390,672
-1,600 Reduced 66.67%
800 $168,000
Q2 2022

Aug 08, 2022
SELL
$174.81 - $241.14 $34,962 - $48,228
-200 Reduced 7.69%
2,400 $566,000
Q1 2022

May 16, 2022
SELL
$166.16 - $213.96 $149,544 - $192,564
-900 Reduced 25.71%
2,600 $466,000
Q4 2021

Feb 14, 2022
SELL
$184.32 - $216.08 $2.56 Million - $3 Million
-13,900 Reduced 79.89%
3,500 $756,000
Q3 2021

Nov 15, 2021
BUY
$179.86 - $214.88 $467,636 - $558,688
2,600 Added 17.57%
17,400 $3.21 Million
Q2 2021

Aug 16, 2021
SELL
$170.47 - $211.93 $801,209 - $996,071
-4,700 Reduced 24.1%
14,800 $2.66 Million
Q1 2021

May 17, 2021
SELL
$153.94 - $174.85 $200,122 - $227,305
-1,300 Reduced 6.25%
19,500 $3.26 Million
Q4 2020

Feb 16, 2021
BUY
$101.87 - $151.79 $1.24 Million - $1.85 Million
12,200 Added 141.86%
20,800 $3.16 Million
Q3 2020

Nov 16, 2020
BUY
$99.9 - $121.13 $69,930 - $84,791
700 Added 8.86%
8,600 $869,000
Q2 2020

Aug 14, 2020
BUY
$92.74 - $125.82 $157,658 - $213,894
1,700 Added 27.42%
7,900 $956,000
Q1 2020

May 15, 2020
SELL
$79.39 - $115.35 $2.46 Million - $3.58 Million
-31,000 Reduced 83.33%
6,200 $588,000
Q4 2019

Feb 14, 2020
BUY
$78.31 - $95.34 $2.5 Million - $3.04 Million
31,900 Added 601.89%
37,200 $3.28 Million
Q3 2019

Nov 14, 2019
SELL
$74.85 - $85.99 $1.84 Million - $2.12 Million
-24,600 Reduced 82.27%
5,300 $423,000
Q2 2019

Aug 14, 2019
BUY
$76.06 - $120.81 $1.65 Million - $2.62 Million
21,700 Added 264.63%
29,900 $2.33 Million
Q1 2019

May 15, 2019
BUY
$107.15 - $126.84 $364,310 - $431,256
3,400 Added 70.83%
8,200 $962,000
Q4 2018

Feb 14, 2019
SELL
$101.4 - $128.73 $618,540 - $785,252
-6,100 Reduced 55.96%
4,800 $523,000
Q3 2018

Nov 14, 2018
BUY
$113.81 - $129.46 $705,622 - $802,652
6,200 Added 131.91%
10,900 $1.39 Million
Q2 2018

Aug 14, 2018
BUY
$101.14 - $118.31 $475,358 - $556,057
4,700 New
4,700 $532,000

Others Institutions Holding UTHR

# of Institutions
671
Shares Held
42.3M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email